Rv3919c - p.Glu170*
Drug resistance types
0 Sensitive
1 RR-TB
4 HR-TB
9 MDR-TB
11 Pre-XDR-TB
1 XDR-TB
3 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.5 | 13 |
| lineage4.6.2.2 | 1 |
| lineage2.2.1;lineage4.5 | 1 |
| lineage1.1.1.1 | 2 |
| lineage4.1.1.1 | 1 |
| lineage4.1.2.1 | 4 |
| lineage3 | 3 |
| lineage4.8 | 2 |
| lineage2.2.1;lineage3.1.2.1 | 1 |
| lineage4.2.2 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 29 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR833216 | Pre-XDR-TB | lineage4.5 | None | ERR2851368 | Other | lineage4.6.2.2 | lb | ERR13290848 | Pre-XDR-TB | lineage2.2.1;lineage4.5 | None | ERR13290946 | MDR-TB | lineage4.5 | None | SRR1011521 | Pre-XDR-TB | lineage4.5 | None | SRR5065587 | Other | lineage1.1.1.1 | vn | SRR1019192 | Pre-XDR-TB | lineage4.5 | None | SRR11972445 | MDR-TB | lineage4.1.1.1 | None | SRR14802162 | Other | lineage4.1.2.1 | None | ERR2510403 | Pre-XDR-TB | lineage3 | pk | ERR779856 | HR-TB | lineage4.1.2.1 | pe | ERR2510599 | MDR-TB | lineage4.8 | None | ERR2510155 | HR-TB | lineage4.1.2.1 | pe | ERR13290917 | Pre-XDR-TB | lineage4.5 | None | ERR13260599 | HR-TB | lineage4.1.2.1 | None | ERR13290925 | RR-TB | lineage4.5 | None | SRR10040214 | MDR-TB | lineage4.5 | None | ERR4797884 | XDR-TB | lineage2.2.1;lineage3.1.2.1 | in | SRR3647353 | MDR-TB | lineage4.2.2 | None | ERR2510636 | MDR-TB | lineage4.8 | pk | ERR13291058 | Pre-XDR-TB | lineage4.5 | None | SRR30180260 | MDR-TB | lineage4.5 | None | SRR6964536 | Pre-XDR-TB | lineage3 | None | SRR833219 | Pre-XDR-TB | lineage4.5 | None | SRR1011522 | Pre-XDR-TB | lineage4.5 | None | SRR1011518 | Pre-XDR-TB | lineage4.5 | None | ERR13290971 | MDR-TB | lineage4.5 | None | SRR29441010 | HR-TB | lineage1.1.1.1 | None | SRR29772406 | MDR-TB | lineage3 | None |
|---|
